Sparing confirmatory testing in primary aldosteronism: the combination of renin, aldosterone and potassium levels
Not Applicable
Completed
- Conditions
- Primary aldosteronismNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN34186253
- Lead Sponsor
- St. Luke's Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 133
Inclusion Criteria
Current inclusion criteria as of 21/06/2024:
Patients above 18 years of age who underwent saline infusion test between January 2010 and March 2024 will be included in this study.
Previous inclusion criteria:
Patients above 18 years of age who underwent saline infusion test between January 2010 and July 2023 will be included in this study.
Exclusion Criteria
Those who did not complete the saline infusion test or did not comply with the saline infusion protocol will be excluded
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aldosterone elevation, plasma renin activity, and hypokalemia obtained at baseline (screening values’)<br>through electronic health records.
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures